Patent holdings for IPC class C07D 207/27

Total number of patents in this class: 339

10-year publication summary

25
23
25
18
28
24
19
31
24
4
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

Principal owners for this class

Owner
All patents
This class
Zhejiang Huahai Pharmaceutical Co., Ltd.
178
13
Modernatx, Inc.
1181
10
Novartis AG
11238
7
Bristol-myers Squibb Company
5080
7
California Institute of Technology
3884
7
ISP Investments Inc.
485
7
Zhejiang Huahai Zhicheng Pharmaceutical Co., Ltd
30
7
E. I. du Pont de Nemours and Company
4345
6
PTC Therapeutics, Inc.
492
6
Takeda Pharmaceutical Company Limited
2961
5
Eli Lilly and Company
3645
5
FMC Corporation
910
4
Mitsubishi Tanabe Pharma Corporation
579
4
PharmaZell GmbH
37
4
Queen's University at Kingston
517
4
Shanghai Syncores Technologies Inc. Ltd
29
4
Taisho Pharmaceutical Co., Ltd.
844
4
Toyama Chemical Co., Ltd.
114
4
Zhejiang Huahai Tiancheng Pharmaceutical Co., Ltd
12
4
The Regents of the University of California
18943
3
Other owners 224